Earnings season is a good time to check in on the most prominent medtech companies in the public sector to see what kind of a quarter they had and what rest of the year looks like for the industry.
Please note, however, that most of the commentary on the following slides came out of fourth-quarter earnings calls that were held before the coronavirus (COVID-19) had spread beyond China.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,